申请人:Ludwig Institute for Cancer Research Ltd
公开号:US20200237763A1
公开(公告)日:2020-07-30
Described inter alia are compounds according to formula (I): or a pharmaceutically acceptable salt thereof, and uses in methods for the modulation of flap endonuclease 1 (FEN1), Xeroderma Pigmentosum Complementation Group G protein (XPG), Exonuclease 1 (EXO1) and/or GEN1.